Patients receiving Polivy plus R-CHP for DLBCL reported similar health-related quality of life outcomes
The new eye hospital in Vashi is ASG’s second in the Mumbai Metropolitan Region (MMR) and the sixth in Maharashtra
Presentations include new data on investigational medicines – favezelimab (MK-4280), zilovertamab vedotin (MK-2140) and nemtabrutinib – as well as KEYTRUDA (pembrolizumab) in multiple blood cancers
The voluntary program is the first time the FDA will allow excipient manufacturers to obtain review of certain novel excipients prior to their use in drug formulations.
The need for hot-melt extrusion (HME) polymers is expected to grow as the pharma industry moves to implement more continuous and sustainable processes.
The capital expansion program commenced in June 2022 and is expected to complete in 2024
Man lost 54 Kgs in 6 months with MGB procedure
The total financial outlay of the scheme is Rs.500 crore for a period of five years from 2021-22 to 2025-26.
The tenure of contract will be upto 10 years from date of signing the contract/installation.
The dashboard will serve as a single source of truth for public and PM-JAY stakeholders providing comprehensive view of scheme’s progress
Subscribe To Our Newsletter & Stay Updated
